Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1097/QCO.0000000000000058

http://scihub22266oqcxt.onion/10.1097/QCO.0000000000000058
suck pdf from google scholar
C4097387!4097387 !24685549
unlimited free pdf from europmc24685549
    free
PDF from PMC    free
html from PMC    free

Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=24685549 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215

suck abstract from ncbi


Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\24685549 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117
pmid24685549
      Curr+Opin+Infect+Dis 2014 ; 27 (3 ): 282-7
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Preparing for an era of untreatable gonorrhea #MMPMID24685549
  • Barbee LA
  • Curr Opin Infect Dis 2014[Jun]; 27 (3 ): 282-7 PMID24685549 show ga
  • PURPOSE OF REVIEW: The proportion of Neisseria gonorrhoeae isolates with reduced susceptibility to extended-spectrum cephalosporins (ESCs) has increased rapidly since 2006. Clinicians, researchers, and public health officials need to be prepared for the possibility of an era of untreatable gonorrhea. This review focuses on the evidence for current gonorrhea treatment recommendations, potential future treatment options, and other methods to control gonorrhea. RECENT FINDINGS: In addition to an increase in isolates with decreased susceptibility to ESCs, there have been reported treatment failures to both cefixime and ceftriaxone. In response, some countries have increased the recommended cephalosporin dose, and most now recommend dual therapy with an ESC and azithromycin. The pharynx has been implicated as a site for acquiring resistance through transformation with commensal Neisseria species or induced resistance through subtherapeutic antimicrobial levels. Thus, appropriate screening of the pharynx and treatment with a regimen that eradicates gonorrhea from the pharynx is necessary. At present, several studies are evaluating various novel treatment regimens in preparation for an era of untreatable gonorrhea. SUMMARY: Screening for asymptomatic infections, maintaining culture capacity to monitor antimicrobial resistance, treating with ceftriaxone and azithromycin, and ensuring that all sexual partners are treated are among the best strategies to control gonorrhea in the current clime.
  • |Anti-Bacterial Agents/*administration & dosage [MESH]
  • |Azithromycin/administration & dosage [MESH]
  • |Cefixime/administration & dosage [MESH]
  • |Ceftriaxone/administration & dosage [MESH]
  • |Cephalosporin Resistance/*drug effects/genetics [MESH]
  • |Cephalosporins/*administration & dosage [MESH]
  • |Drug Administration Schedule [MESH]
  • |Gonorrhea/drug therapy/*microbiology [MESH]
  • |Humans [MESH]
  • |Microbial Sensitivity Tests [MESH]
  • |Neisseria gonorrhoeae/drug effects/genetics/*isolation & purification [MESH]
  • |Pharynx/*microbiology [MESH]
  • |Population Surveillance [MESH]
  • |Practice Guidelines as Topic [MESH]
  • |Public Health [MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box